Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 over 90% of them in Africa QIAprep&amp Plasmodium Kit enables streamlined detection ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

Professor Markus Meißner from LMU Munich and Professor of Biochemistry Gernot Längst from the University of Regensburg led the study team, which found how PfSnf2L is essential for P. falciparum ...

for prevention of P. falciparum malaria in healthy malaria-naive adults. BioNTech shares fell 3.4% to close at $110.83 on Thursday. Benzinga readers can access the latest analyst ratings on the ...

The Phase I/II trial (NCT06069544) has enrolled 177 healthy volunteers into a trial to test the safety, efficacy and pharmacokinetics (PK) of its mRNA-based vaccine for P. falciparum malaria in ...

Get Instant Summarized Text (Gist) A new approach for antimalarial drug development involves using a 'Trojan horse' strategy with prodrugs activated by the human enzyme acylpeptide hydrolase (APEH ...

The trial, opens new tab was to evaluate the safety and efficacy of the RNA-based vaccine called BNT165e for prevention of malaria caused by the P. falciparum parasite in healthy adults who have ...

Commissions do not affect our editors' opinions or evaluations. The price-to-earnings ratio, or P/E ratio, helps you compare the price of a company’s stock to the earnings the company generates.

Health authorities are conducting tests in regions of DR Congo affected by a mystery disease that has killed 60 people. https://p.dw.com/p/4rC2q Plasmodium falciparum ...

Researchers grew Plasmodium knowlesi in rhesus macaque red blood cells to study which genes are critical for P. knowlesi survival. Image credit: Sheena Dass Malaria affects about 249 million people ...